Company / Depreciation & Amortization
Baxter International Depreciation & Amortization History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$981.0M
FY2025
5-year range
$867.0M / $1.1B
FY2021-FY2025
Trend
-1.6%
vs FY2024
Sector context
#15 of 142
Health Care
What the data says
Baxter International's depreciation & amortization of $981M is higher than 89% of companies in the Health Care sector (FY2025). Depreciation & Amortization has fluctuated over the past 10 years, ranging from $750M in FY2019 to $1.1B in FY2022.
Based on SEC 10-K filings.
$981M in FY2025 with a 5-year CAGR of +3.6%. Top quartile in the Health Care sector.
Remained stable around $981M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -2.9%
- 5-Year CAGR
- +3.6%
- 10-Year CAGR
- -
Sector benchmark
+182.4% above sector average
Key checks
Key Insights
- 5-year CAGR of +3.6%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 1.6% year-over-year.
- Ranks #15 out of 142 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2022.
Company context
Key Data Points
- Negative profit margin: -6.1%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $981.0M | -1.6% |
| FY2024 | $997.0M | +1.3% |
| FY2023 | $984.0M | -8.2% |
| FY2022 | $1.1B | +23.6% |
| FY2021 | $867.0M | +5.3% |
| FY2020 | $823.0M | +9.7% |
| FY2019 | $750.0M | -2.7% |
| FY2018 | $771.0M | +2.8% |
| FY2017 | $750.0M | -5.3% |
| FY2016 | $792.0M | +4.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026